- Home
- BRSP vs EMBC Comparison
BRSP vs EMBC Comparison
Compare BRSP & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRSP
- EMBC
- Stock Information
- Founded
- BRSP 2017
- EMBC 1924
- Country
- BRSP United States
- EMBC United States
- Employees
- BRSP N/A
- EMBC N/A
- Industry
- BRSP Real Estate Investment Trusts
- EMBC Medical/Dental Instruments
- Sector
- BRSP Real Estate
- EMBC Health Care
- Exchange
- BRSP Nasdaq
- EMBC Nasdaq
- Market Cap
- BRSP 730.1M
- EMBC 753.0M
- IPO Year
- BRSP 2018
- EMBC N/A
- Fundamental
- Price
- BRSP $5.71
- EMBC $18.63
- Analyst Decision
- BRSP Hold
- EMBC Buy
- Analyst Count
- BRSP 5
- EMBC 2
- Target Price
- BRSP $7.06
- EMBC $19.00
- AVG Volume (30 Days)
- BRSP 631.6K
- EMBC 445.2K
- Earning Date
- BRSP 02-19-2025
- EMBC 02-07-2025
- Dividend Yield
- BRSP 11.28%
- EMBC 3.26%
- EPS Growth
- BRSP N/A
- EMBC 9.84
- EPS
- BRSP N/A
- EMBC 1.34
- Revenue
- BRSP $378,095,000.00
- EMBC $1,123,100,000.00
- Revenue This Year
- BRSP N/A
- EMBC $0.26
- Revenue Next Year
- BRSP N/A
- EMBC $1.24
- P/E Ratio
- BRSP N/A
- EMBC $13.75
- Revenue Growth
- BRSP N/A
- EMBC 0.21
- 52 Week Low
- BRSP $5.07
- EMBC $9.93
- 52 Week High
- BRSP $7.71
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- BRSP 43.81
- EMBC 42.20
- Support Level
- BRSP $5.40
- EMBC $19.17
- Resistance Level
- BRSP $5.85
- EMBC $20.63
- Average True Range (ATR)
- BRSP 0.15
- EMBC 0.86
- MACD
- BRSP 0.01
- EMBC -0.33
- Stochastic Oscillator
- BRSP 51.69
- EMBC 8.93
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.
About EMBC Embecta Corp.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.